glp 1 gip dual agonist lilly Eli Lilly's GIP/GLP-1 Tirzepatide: Lowering Blood Sugar, Weight, And Cardiovascular Risk! - Industry news - News Eli Lilly's GIP/GLP-1 Dual Agonist
Description
Eric Topol: GLP-1 Drugs Reduce Substance Abuse Risk in Over 600,000 US Veterans / cancer, Eric Topol, GLP-1, OncoDaily, Oncology
Originally developed to treat type 2 diabetes (T2D), these drugs have since delivered major advances in managing obesity and cardiovascular risk reduction
GLP-1 agonists are regularly prescribed by doctors for patients with Type 2 Diabetes. And now theyre the next big thing in the weight loss world.
They work by mimicking the effects of the naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which is responsible for regulating insulin and blood sugar levels
From ending obesity to decreasing violence how far can GLP-1s go?
